Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients

NCT00277641 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.

NCT NCT00277641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients
Lead sponsor
Lindner Center of HOPE
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2009
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder, obesity